BIOMAT Database Logo BIOMAT Database Logo

Targeted drug delivery systems for pancreatic cancer. 2014

Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta

Pancreatic cancer is usually diagnosed at the advanced stages, responds poorly to the available chemotherapeutics and constitutes the major factor for high mortality rate. Selective delivery of therapeutics to their cellular targets, without side effects is the foremost objective of the current investigations for effective treatment of pancreatic cancer. The development of the drugs which can selectively target pancreatic cancer along with carriers that can deliver drugs specifically to the rapidly dividing cells is considered as magic bullet for the efficient treatment of this fatal disease. This review describes various factors hampering the efficacy of drug targeting to pancreatic cancer including stromal fortress, hypocascularity, hyaluronan and interstitial fluid pressure, and exploration of various cellular targets for the site specific drug delivery. An account of burgeoning applications of novel drug delivery systems including nanoparticles, liposomes, quantum dots, micelles and drug conjugates in the management of pancreatic cancer is also provided. Additionally, potential of target based therapeutic agents and nanomedicines in clinical trials for the pancreatic cancer therapy are highlighted.

UI MeSH Term Description Entries
D008297 Male Males
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D050997 Nanomedicine The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).
D053769 Nanocapsules Nanometer-sized, hollow, spherically-shaped objects that can be utilized to encapsulate small amounts of pharmaceuticals, enzymes, or other catalysts (Glossary of Biotechnology and Nanobiotechnology, 4th ed). Nanocapsule
D058990 Molecular Targeted Therapy Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease. Targeted Molecular Therapy,Molecular Targeted Therapies,Molecular Therapy, Targeted,Targeted Molecular Therapies,Targeted Therapy, Molecular,Therapy, Molecular Targeted,Therapy, Targeted Molecular

Related Publications

Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta
Review of design strategies for active targeted drug delivery systems for pancreatic cancer.
January 2026, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta
Targeted drug delivery in pancreatic cancer.
January 2010, Biochimica et biophysica acta,
Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta
LHRH-Targeted Drug Delivery Systems for Cancer Therapy.
January 2017, Mini reviews in medicinal chemistry,
Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta
Functionalized micellar systems for cancer targeted drug delivery.
June 2007, Pharmaceutical research,
Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta
Review targeted drug delivery systems for norcantharidin in cancer therapy.
December 2022, Journal of nanobiotechnology,
Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta
Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy.
January 2023, International journal of nanomedicine,
Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta
Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy.
January 2020, Current drug targets,
Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta
Targeted drug and gene delivery systems for lung cancer therapy.
December 2009, Clinical cancer research : an official journal of the American Association for Cancer Research,
Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta
Targeted Drug Delivery Systems for Kidney Diseases.
January 2021, Frontiers in bioengineering and biotechnology,
Vaibhav Khare, and Noor Alam, and Ankit Saneja, and Ravindra Dhar Dubey, and Prem N Gupta
[Pharmacokinetics model for targeted drug delivery systems].
March 1993, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
Copied contents to your clipboard!